# US 2012/0252030 A1 · 5-bromo-2'-deoxy-uridine labeled nucleotide triphosphates and nucleic acid probes and methods of making and using the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252030 A1
- Document ID: US20120252030A1
- Status: Published application
- Kind: A1
- Application number: 13/438,749
- Filed: 2012-04-03
- Published: 2012-10-04
- Earliest claimed: 2007-06-14
- Assignees: Life Technologies Corporation
- Inventors: Anilkumar R. KORE; Zhongting Hu
- Web page: https://patentgrep.com/patent/US20120252030A1

## CPC

- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

5-bromo-2′-deoxy-uridine (BrdU) labeled nucleotide triphosphates and nucleic acid probes are described herein. The BrdU labeled nucleotide triphosphates include a linker between the nucleotide triphosphate and the BrdU moiety. The linker can be cleavable or non-cleavable. The nucleotide triphosphates can be a ribonucleotide triphosphates, 2′-deoxyribonucleotide triphosphates or 2′,3′-dideoxyribonucleotide triphosphates. The nucleic acid probes can be used for in situ hybridization.

## Claims

### Claim 1

A compound of the formula:
or a salt thereof, wherein “Nu” is a nucleotide triphosphate, a 2′-deoxynucleotide triphosphate or a 2′,3′-dideoxynucleotide triphosphate and wherein L is a linker.

### Claim 2 (depends on 1)

The compound of claim 1, wherein L has a length greater than a C11 n-alkane carbon chain.

### Claim 3 (depends on 1)

The compound of claim 1, wherein “Nu” is uridine triphosphate, 2′-deoxyuridine triphosphate or 2′,3′-dideoxytriphosphate.

### Claim 4 (depends on 1)

The compound of claim 1, wherein the compound is of the formula:
or a salt thereof, wherein each X is independently H or OH and “L” is a linker.

### Claim 5 (depends on 1)

The compound of claim 1, wherein “L” is a linker having a chemical structure selected from the group consisting of:
wherein n is an integer of from 6 to 12.

### Claim 6 (depends on 1)

A sodium salt of the compound of claim 1.

### Claim 7 (depends on 1)

The compound of claim 1, wherein the compound is of the formula:
or a salt thereof, wherein each X is independently H or OH.

### Claim 8 (depends on 7)

A sodium salt of the compound of claim 7.

### Claim 9

A polynucleotide represented by the formula:
wherein “Y” is a nucleoside, a nucleotide or a polynucleotide, “Z” is H, a nucleotide or a polynucleotide, “X” is H or OH, “B” is a nucleobase and “L” is a linker.

### Claim 10 (depends on 9)

The polynucleotide of claim 9, wherein the polynucleotide is represented by the formula:
wherein “Y” is a nucleoside, nucleotide or polynucleotide, “Z” is H, a nucleotide or a polynucleotide, “X” is H or OH and “L” is a linker.

### Claim 11 (depends on 9)

The polynucleotide of claim 9, wherein “L” is a linker having a chemical structure selected from the group consisting of:
wherein n is an integer of from 6 to 12.

### Claim 12

(canceled)

### Claim 13 (depends on 9)

A method for detecting the presence of a nucleic acid analyte in a tissue sample comprising:
incubating the tissue sample with a composition comprising the polynucleotide of claim 9, wherein the polynucleotide binds to the nucleic acid analyte;
washing the sample;
contacting the sample with an anti-BrdU antibody conjugated to a detectable moiety or to an enzyme; and
detecting the detectable moiety or enzyme.

### Claim 14 (depends on 13)

The method of claim 13, further comprising fixing the sample prior to incubating the sample.

### Claim 15 (depends on 14)

The method of claim 14, wherein fixing comprises contacting the sample with an acid or a cross-linking agent.

### Claim 16 (depends on 1)

A composition comprising:
adenosine triphosphate (ATP);
uridine triphosphate (UTP);
guanosine triphosphate (GTP);
cytidine triphosphate (CTP); and
a compound as set forth in claim 1, wherein “Nu” is a nucleotide triphosphate.

### Claim at position 17

17-25. (canceled)
